Moderna soars on analyst upgrade Moderna’s stock surges on positive analyst outlook, reflecting the potential of its innovative mRNA-based vaccines and therapies. Previous Article New Law Will Change the Way Tourists Can Walk the Las Vegas Strip Next Article 7 Hidden Signs of Autism in Adults
